Trials / Terminated
TerminatedNCT00038779
Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States
Megadose T-cell Depleted HLA-nonidentical Blood Progenitor Cell Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- M.D. Anderson Cancer Center · Academic / Other
- Sex
- All
- Age
- 49 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess early treatment failure within 100 days and to assess the effect of this regimen on engraftment, GVHD, immune recovery, relapse of malignancy and survival.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Megadose T-cell Depleted HLA-nonidentical Blood Progenitor Cell Transplantation |
Timeline
- Start date
- 1996-08-14
- Primary completion
- 2004-09-20
- Completion
- 2004-09-20
- First posted
- 2002-06-07
- Last updated
- 2018-10-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00038779. Inclusion in this directory is not an endorsement.